Success Case: Israel Study Tour For Ukrainian Pharmaceutical Company
One of Ukraine’s major pharmaceutical companies has recently returned from an IUA-led study tour that took place on November 22-26 in Israel. This was a deep dive into biotech, a primary sphere of interest for our client.
How It Was
Following our Client's request, the Alliance organized meetings with leading Israeli biotechnology companies (Canfite, Sarel, Ayana Pharma, etc.), as well as with heads of well-known hospitals (e.g. Sheba Medical Central), the Ambassador of Ukraine to Israel, and the Technion Research and Development Foundation.
“The Israeli ecosystem is the result of collaboration between highly competitive academic and research organizations, experienced manufacturers, top medical infrastructure, and financial institutions that draw liquidity from the world's largest financial markets,” said Eugene Nayshtetik, managing partner at Lorton Investments. “Additionally, the Israeli biotech is very efficient in terms of technology transfer with 4 large and dozens of smaller technology transfer offices. Although it is hard to imagine what can make technologies for growing blood vessels, organ and tissue printing, highly efficient synthesis of small molecules, reprogramming of cells, and others ever more attractive. There is always something to work with for those who are involved in technological development both at the translation stage and at later stages.”
In addition, the Israeli-Ukrainian Alliance has provided necessary organizational and logistical preparations for the Client to pitch early-stage biotechnology, Life Science, and MedTech startups.
The Client is currently analyzing the experience gained in Israel and deciding on the possibility of acquiring biological technologies and investing in promising Israeli startups.
Benefits of Study Tours
Study tours are extremely effective when the Client feels the need for a deep immersion in one or more business ecosystems in Israel. This can be biotech, agriculture or agritech, food tech, educational and management tours. Typically, our study tours include getting closely acquainted with key institutions, companies, and government agencies that are of interest to our partners.
At the same time, the Alliance sets up all the necessary meetings and handles logistics (tickets, hotels, transfers, food, etc.)
According to Anna Zharova, CEO of the Israeli-Ukrainian Alliance, study tours – despite online solutions available on the market – are a surprisingly effective tool for immersing oneself in the Israeli ecosystem. Here’s what makes them so special:
1) For pharma, biotech, agritech, food tech, and other corporations study tours remain a valuable source of exclusive contacts and knowledge.
2) Israel is a comprehensive and relatively inexpensive source of knowledge offering easy access to many ambitious startups, companies, and investors.
3) Study tours are, in fact, one of the few ways that can result in lasting partnerships and open new opportunities for Ukrainian companies seeking faster and more effective development.
P.S. Are you interested in study tours? Please get in touch with Anna Zharova [email protected] who will gladly advise you on the options that would work best for you and your business.
Tectonic 2021: How Israel And Ukraine Are Crafting Stronger Friendship
2021 will be remembered not only as another year in a new COVID-19 driven reality but also as a year marked by several important dates shared by Israel and Ukraine that we at the Israeli-Ukrainian Alliance have no right to ignore
Hummu Sapiens Open Their First Hummusia In Kyiv
Modern restaurant of Israeli and Middle Eastern cuisine opened its door on Saturday, December 18, in the historic Podil district of the capital
In Cybersecurity, Israel Has Become a Breeding Ground For Billion-Dollar Startups
Articles in the media and speeches of politicians are full of theses about Ukrainian talents and number of graduates specializing in IT. But does Ukraine respect its human capital? Does it invest in its people, their ambitions, skills and experience? Perhaps. But it can do even better.